Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
IT | 965 kB | 926 |
August 2021 | Version 4.0 / Guida allegata EN - Cambiamenti Ed. 4.0 in calce
La guida descrive le modalità di registrazione di una sostanza ai se...
ID 10681 | Rev. 2.0 del 24.05.2020 - Documento PDF completo Allegato
Note Rev. 2.0 del 24.05.2020
La Rev. 2.0 del 24.05.2020 ti...
ID 19856 | 21.06.2023
Regolamento di esecuzione (UE) 2023/1195 della Commissione del 20 giugno 2023 che stabilisce norme relative ai dettagli e al formato delle...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024